NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX total assets
Total assets on the balance sheet at the end of each period.
NewcelX's total assets was $9.70M at Jun 30, 2026. For fiscal 2025 it was $11.45M, up 1167.4% from the year before. The highest annual figure on record is $11.45M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.45M | +1167.4% |
| FY2024 | Dec 31, 2024 | $903.00K | -51.1% |
| FY2023 | Dec 31, 2023 | $1.85M | -80.1% |
| FY2022 | Dec 31, 2022 | $9.28M | +60.9% |
| FY2021 | Dec 31, 2021 | $5.76M | +375.8% |
| FY2020 | Dec 31, 2020 | $1.21M | +74.0% |
| FY2019 | Dec 31, 2019 | $696.43K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.70M | +712.8% |
| Q4 FY2025 | Dec 31, 2025 | $11.45M | +519.8% |
| Q2 FY2025 | Jun 30, 2025 | $4.34M | +91.1% |
| Q4 FY2024 | Dec 31, 2024 | $903.00K | -90.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.19M | -42.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.85M | -68.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.27M | -72.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.28M | +665.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.06M | +195.5% |
| Q4 FY2021 | Dec 31, 2021 | $5.76M | – |
| Q2 FY2021 | Jun 30, 2021 | $8.27M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.21M | – |
| Q4 FY2019 | Dec 31, 2019 | $696.43K | – |
See a number that looks wrong?